Susan Moran - 16 Jun 2022 Form 4 Insider Report for BioAtla, Inc. (BCAB)

Role
Director
Signature
/s/ Christian Vasquez, as Attorney-in-Fact for Susan Moran
Issuer symbol
BCAB
Transactions as of
16 Jun 2022
Net transactions value
$0
Form type
4
Filing time
17 Jun 2022, 19:51:38 UTC
Previous filing
16 Jun 2021
Next filing
15 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCAB Stock Option (right to buy) Award $0 +20,000 $0.000000 20,000 16 Jun 2022 Common Stock 20,000 $2.48 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the total number of shares subject to the option shall vest and become exercisable on the earlier of (a) June 16, 2023 or (b) the next annual meeting of stockholders, subject to the reporting person continuing to provide services through the vesting date.